BRAF and cancer: Taken together, our results suggest that: (i) BRAF driver gene shows a dominant or “wave” role across all stages, (ii) one to three driver genes exhibit a dominant role in certain stages; (iii) common genes, differently mutated across clinical stages, drive the cancer cells developing from early to advanced stages and highlight the dynamic changes of PTC oncogenesis (Fig. 5).